Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vanda Pharmaceuticals
Pharma
Supreme Court rejects Vanda's Hetlioz patent revival appeal
The U.S. Supreme Court has rebuffed Vanda's bid to revive patents on its 10-year-old sleep disorder drug Hetlioz following a 2023 appeals court loss.
Fraiser Kansteiner
Apr 22, 2024 3:49pm
Vanda turns back on hostile takeover bid by CDMO Future Pak
Apr 18, 2024 11:01am
15 years later, Vanda secures another FDA nod for Fanapt
Apr 3, 2024 11:04am
FDA shoots down Vanda hearing request over Hetlioz rejection
Mar 5, 2024 2:05pm
J&J unloads certain Ponvory rights to Vanda for $100M
Dec 7, 2023 11:57pm
Vanda scores courtroom win over FDA in records case
Mar 29, 2023 3:15pm